GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » YoY EPS Growth

Jiang Xinxin Medtec Co (SZSE:300453) YoY EPS Growth : 0.00% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Jiang Xinxin Medtec Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was 0.00%.

Jiang Xinxin Medtec Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ¥0.10.

Jiang Xinxin Medtec Co YoY EPS Growth Historical Data

The historical data trend for Jiang Xinxin Medtec Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co YoY EPS Growth Chart

Jiang Xinxin Medtec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.32 35.29 20.07 10.86 10.80

Jiang Xinxin Medtec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.39 16.09 17.82 -5.60 -

Jiang Xinxin Medtec Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Jiang Xinxin Medtec Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(0.441-0.398)/ | 0.398 |
=10.80 %

Jiang Xinxin Medtec Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(0.103-0.103)/ | 0.103 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiang Xinxin Medtec Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiang Xinxin Medtec Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » YoY EPS Growth
Comparable Companies
SHSE:605369 SHSE:688410 SZSE:301580 SZSE:300358 SZSE:000931 SZSE:301093 SHSE:603205 SHSE:603309 SHSE:688677 SZSE:300981 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, Nanchang, CHN, 330200
Website
http://www.sanxin-med.com
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.
Executives
Zhang Lin Supervisors
Le Zhen Rong Executives
Mao Zhi Ping Directors, executives
Yu Zhen Zhu Supervisors
Peng Yi Xing Director
Liu Ming Securities Affairs Representative
Wan Xiao Ping Director
Wang Qin Hua Supervisors
Xiong Yan Supervisors

Jiang Xinxin Medtec Co Headlines

No Headlines